{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:43:13Z","timestamp":1771576993039,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Polish Ministry of Education and Science"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s43440-025-00703-y","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T13:45:50Z","timestamp":1739195150000},"page":"517-531","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative analysis of risedronate and its regioisomers synthesized via microwave-assisted method: bone affinity, cytotoxicity, permeability, and therapeutic potential"],"prefix":"10.1007","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8850-6270","authenticated-orcid":false,"given":"Monika","family":"Zieli\u0144ska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Pacholak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bartosz","family":"Orwat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariusz","family":"Sandomierski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ireneusz","family":"Kownacki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Kaczorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Voelkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"703_CR1","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/TCRM.S138000","volume":"14","author":"F Pouresmaeili","year":"2018","unstructured":"Pouresmaeili F, KamaliDehghan B, Kamarehei M, Yong MG. A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag. 2018;14:2029\u201349. https:\/\/doi.org\/10.2147\/TCRM.S138000.","journal-title":"Ther Clin Risk Manag"},{"key":"703_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/8756-3282(95)00445-9","volume":"18","author":"JH Lin","year":"1996","unstructured":"Lin JH. Bisphosphonates: a review of their pharmacokinetic properties. Bone. 1996;18:75\u201385. https:\/\/doi.org\/10.1016\/8756-3282(95)00445-9.","journal-title":"Bone"},{"key":"703_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161435.GL","volume":"22","author":"PM Camacho","year":"2016","unstructured":"Camacho PM, Petak SM, Binkley N, Clarke BL, Harris ST, Hurley DL, et al. American association of clinical endocrinologists and american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142016. Endocr Pract. 2016;22:1\u201342. https:\/\/doi.org\/10.4158\/EP161435.GL.","journal-title":"Endocr Pract"},{"key":"703_CR4","volume-title":"Osteoporosis","author":"G Clunie","year":"2014","unstructured":"Clunie G, Keen RW. Osteoporosis. 2nd ed. Oxford: Oxford University Press; 2014.","edition":"2"},{"key":"703_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/S0140-6736(18)32112-3","volume":"393","author":"JE Compston","year":"2019","unstructured":"Compston JE, McClung MR, Leslie WD. Osteoporosis. The Lancet. 2019;393:364\u201376. https:\/\/doi.org\/10.1016\/S0140-6736(18)32112-3.","journal-title":"The Lancet"},{"key":"703_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","volume":"49","author":"RGG Russell","year":"2011","unstructured":"Russell RGG. Bisphosphonates: The first 40 years. Bone. 2011;49:2\u201319. https:\/\/doi.org\/10.1016\/j.bone.2011.04.022.","journal-title":"Bone"},{"key":"703_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1196\/annals.1346.041","volume":"1068","author":"RGG Russell","year":"2006","unstructured":"Russell RGG. Bisphosphonates: from bench to bedside. Ann N Y Acad Sci. 2006;1068:367\u2013401. https:\/\/doi.org\/10.1196\/annals.1346.041.","journal-title":"Ann N Y Acad Sci"},{"key":"703_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1196\/annals.1402.089","volume":"1117","author":"RGG Russell","year":"2007","unstructured":"Russell RGG, Xia Z, Dunford JE, Oppermann U, Kwaasi A, Hulley PA, et al. Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci. 2007;1117:209\u201357. https:\/\/doi.org\/10.1196\/annals.1402.089.","journal-title":"Ann N Y Acad Sci"},{"key":"703_CR9","doi-asserted-by":"publisher","first-page":"115407","DOI":"10.1016\/j.bone.2020.115407","volume":"137","author":"MR McClung","year":"2020","unstructured":"McClung MR, Ebetino FH. History of risedronate. Bone. 2020;137:115407. https:\/\/doi.org\/10.1016\/j.bone.2020.115407.","journal-title":"Bone"},{"key":"703_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jconrel.2013.01.032","volume":"167","author":"EV Giger","year":"2013","unstructured":"Giger EV, Castagner B, Leroux J-C. Biomedical applications of bisphosphonates. J Controlled Release. 2013;167:175\u201388. https:\/\/doi.org\/10.1016\/j.jconrel.2013.01.032.","journal-title":"J Controlled Release"},{"key":"703_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bone.2011.03.774","volume":"49","author":"FH Ebetino","year":"2011","unstructured":"Ebetino FH, Hogan A-ML, Sun S, Tsoumpra MK, Duan X, Triffitt JT, et al. The relationship between the chemistry and biological activity of the bisphosphonates. Bone. 2011;49:20\u201333. https:\/\/doi.org\/10.1016\/j.bone.2011.03.774.","journal-title":"Bone"},{"key":"703_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1080\/10426509908546169","volume":"144","author":"FH Ebetino","year":"1999","unstructured":"Ebetino FH. The discovery of the bone-active agent risedronate, and bisphosphonate structure-activity considerations including the aminophenylethane phosphonate series. Phosphorus Sulfur Silicon Relat Elem. 1999;144:9\u201312. https:\/\/doi.org\/10.1080\/10426509908546169.","journal-title":"Phosphorus Sulfur Silicon Relat Elem"},{"key":"703_CR13","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/jbm.b.31500","volume":"92B","author":"MA Lawson","year":"2010","unstructured":"Lawson MA, Xia Z, Barnett BL, Triffitt JT, Phipps RJ, Dunford JE, et al. Differences between bisphosphonates in binding affinities for hydroxyapatite. J Biomed Mater Res B Appl Biomater. 2010;92B:149\u201355. https:\/\/doi.org\/10.1002\/jbm.b.31500.","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"703_CR14","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RGG Russell","year":"2008","unstructured":"Russell RGG, Watts NB, Ebetino FH, Rogers MJ. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int. 2008;19:733\u201359. https:\/\/doi.org\/10.1007\/s00198-007-0540-8.","journal-title":"Osteoporos Int"},{"key":"703_CR15","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jpha.2020.07.011","volume":"11","author":"M Zieli\u0144ska","year":"2021","unstructured":"Zieli\u0144ska M, Chmielewska E, Buchwald T, Voelkel A, Kafarski P. Determination of bisphosphonates anti-resorptive properties based on three forms of ceramic materials: sorption and release process evaluation. J Pharm Anal. 2021;11:364\u201373. https:\/\/doi.org\/10.1016\/j.jpha.2020.07.011.","journal-title":"J Pharm Anal"},{"key":"703_CR16","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1021\/la3046548","volume":"29","author":"P Pascaud","year":"2013","unstructured":"Pascaud P, Gras P, Coppel Y, Rey C, Sarda S. Interaction between a bisphosphonate, tiludronate, and biomimetic nanocrystalline apatites. Langmuir. 2013;29:2224\u201332. https:\/\/doi.org\/10.1021\/la3046548.","journal-title":"Langmuir"},{"key":"703_CR17","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1016\/j.tetlet.2011.03.093","volume":"52","author":"G Keglevich","year":"2011","unstructured":"Keglevich G, Gr\u00fcn A, Aradi K, Garadnay S, Greiner I. Optimized synthesis of N-heterocyclic dronic acids; closing a black-box era. Tetrahedron Lett. 2011;52:2744\u20136. https:\/\/doi.org\/10.1016\/j.tetlet.2011.03.093.","journal-title":"Tetrahedron Lett"},{"key":"703_CR18","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1515\/gps-2013-0107","volume":"3","author":"R Kov\u00e1cs","year":"2014","unstructured":"Kov\u00e1cs R, Grun A, Garadny S, Greiner I. \u201cGreener\u201d synthesis of bisphosphonic\/dronic acid derivatives. Green Process Synth. 2014;3:111\u20136.","journal-title":"Green Process Synth"},{"key":"703_CR19","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.tetlet.2011.02.058","volume":"52","author":"DA Mustafa","year":"2011","unstructured":"Mustafa DA, Kashemirov BA, McKenna CE. Microwave-assisted synthesis of nitrogen-containing 1-hydroxymethylenebisphosphonate drugs. Tetrahedron Lett. 2011;52:2285\u20137. https:\/\/doi.org\/10.1016\/j.tetlet.2011.02.058.","journal-title":"Tetrahedron Lett"},{"key":"703_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","volume":"38","author":"L Di","year":"2003","unstructured":"Di L, Kerns EH, Fan K, McConnell OJ, Carter GT. High throughput artificial membrane permeability assay for blood\u2013brain barrier. Eur J Med Chem. 2003;38:223\u201332. https:\/\/doi.org\/10.1016\/S0223-5234(03)00012-6.","journal-title":"Eur J Med Chem"},{"key":"703_CR21","doi-asserted-by":"publisher","first-page":"116588","DOI":"10.1016\/j.bmc.2021.116588","volume":"56","author":"J Williams","year":"2022","unstructured":"Williams J, Siramshetty V, Nguy\u1ec5n \u00d0-T, Padilha EC, Kabir Md, Yu K-R, et al. Using in vitro ADME data for lead compound selection: an emphasis on PAMPA pH 5 permeability and oral bioavailability. Bioorg Med Chem. 2022;56:116588. https:\/\/doi.org\/10.1016\/j.bmc.2021.116588.","journal-title":"Bioorg Med Chem"},{"key":"703_CR22","doi-asserted-by":"publisher","first-page":"5916","DOI":"10.1038\/s41598-020-62655-y","volume":"10","author":"MJ Foysal","year":"2020","unstructured":"Foysal MJ, Fotedar R, Siddik MAB, Tay A. Lactobacillus acidophilus and L. plantarum improve health status, modulate gut microbiota and innate immune response of marron (Cherax cainii). Sci Rep. 2020;10:5916. https:\/\/doi.org\/10.1038\/s41598-020-62655-y.","journal-title":"Sci Rep"},{"key":"703_CR23","doi-asserted-by":"publisher","first-page":"e00190","DOI":"10.1128\/AEM.00190-20","volume":"86","author":"CC Cheng","year":"2020","unstructured":"Cheng CC, Duar RM, Lin X, Perez-Munoz ME, Tollenaar S, Oh J-H, et al. Ecological importance of cross-feeding of the intermediate metabolite 1,2-propanediol between bacterial gut symbionts. Appl Environ Microbiol. 2020;86:e00190-e220. https:\/\/doi.org\/10.1128\/AEM.00190-20.","journal-title":"Appl Environ Microbiol"},{"key":"703_CR24","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1007\/s00253-019-09844-6","volume":"103","author":"I Garc\u00eda-Cano","year":"2019","unstructured":"Garc\u00eda-Cano I, Rocha-Mendoza D, Ortega-Anaya J, Wang K, Kosmerl E, Jim\u00e9nez-Flores R. Lactic acid bacteria isolated from dairy products as potential producers of lipolytic, proteolytic and antibacterial proteins. Appl Microbiol Biotechnol. 2019;103:5243\u201357. https:\/\/doi.org\/10.1007\/s00253-019-09844-6.","journal-title":"Appl Microbiol Biotechnol"},{"key":"703_CR25","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1007\/s12602-018-9426-7","volume":"11","author":"KB Klopper","year":"2019","unstructured":"Klopper KB, Bester E, Deane SM, Wolfaardt GM, Dicks LMT. Survival of planktonic and sessile cells of Lactobacillus rhamnosus and Lactobacillus reuteri upon exposure to simulated fasting-state gastrointestinal conditions. Probiotics Antimicrob Proteins. 2019;11:594\u2013603. https:\/\/doi.org\/10.1007\/s12602-018-9426-7.","journal-title":"Probiotics Antimicrob Proteins"},{"key":"703_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jff.2014.05.017","volume":"10","author":"M Rattanaprasert","year":"2014","unstructured":"Rattanaprasert M, Roos S, Hutkins RW, Walter J. Quantitative evaluation of synbiotic strategies to improve persistence and metabolic activity of Lactobacillus reuteri DSM 17938 in the human gastrointestinal tract. J Funct Foods. 2014;10:85\u201394. https:\/\/doi.org\/10.1016\/j.jff.2014.05.017.","journal-title":"J Funct Foods"},{"key":"703_CR27","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3390\/nu8070415","volume":"8","author":"M Russo","year":"2016","unstructured":"Russo M, Fabersani E, Abeij\u00f3n-Mukdsi M, Ross R, Fontana C, Ben\u00edtez-P\u00e1ez A, et al. Lactobacillus fermentum CRL1446 ameliorates oxidative and metabolic parameters by increasing intestinal feruloyl esterase activity and modulating microbiota in caloric-restricted mice. Nutrients. 2016;8:415. https:\/\/doi.org\/10.3390\/nu8070415.","journal-title":"Nutrients"},{"key":"703_CR28","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s10620-012-2310-5","volume":"57","author":"H Alagozlu","year":"2012","unstructured":"Alagozlu H, Karakan T. Probiotics are sensitive microorganisms: lactobacillus can be affected by stomach acid, antibiotic, and bowel cleansing. Dig Dis Sci. 2012;57:2477\u20138. https:\/\/doi.org\/10.1007\/s10620-012-2310-5.","journal-title":"Dig Dis Sci"},{"key":"703_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.bcp.2016.09.023","volume":"122","author":"IS Kim","year":"2016","unstructured":"Kim IS, Yoo D-H, Jung I-H, Lim S, Jeong J-J, Kim K-A, et al. Reduced metabolic activity of gut microbiota by antibiotics can potentiate the antithrombotic effect of aspirin. Biochem Pharmacol. 2016;122:72\u20139. https:\/\/doi.org\/10.1016\/j.bcp.2016.09.023.","journal-title":"Biochem Pharmacol"},{"key":"703_CR30","doi-asserted-by":"publisher","first-page":"109653","DOI":"10.1016\/j.biopha.2019.109653","volume":"121","author":"X Li","year":"2020","unstructured":"Li X, Liu L, Cao Z, Li W, Li H, Lu C, et al. Gut microbiota as an \u201cinvisible organ\u201d that modulates the function of drugs. Biomed Pharmacother. 2020;121:109653. https:\/\/doi.org\/10.1016\/j.biopha.2019.109653.","journal-title":"Biomed Pharmacother"},{"key":"703_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1471-2180-12-47","volume":"12","author":"A Rehman","year":"2012","unstructured":"Rehman A, Heinsen F-A, Koenen ME, Venema K, Knecht H, Hellmig S, et al. Effects of probiotics and antibiotics on the intestinal homeostasis in a computer controlled model of the large intestine. BMC Microbiol. 2012;12:47. https:\/\/doi.org\/10.1186\/1471-2180-12-47.","journal-title":"BMC Microbiol"},{"key":"703_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.acthis.2018.03.007","volume":"120","author":"E Grela","year":"2018","unstructured":"Grela E, Koz\u0142owska J, Grabowiecka A. Current methodology of MTT assay in bacteria\u2014a review. Acta Histochem. 2018;120:303\u201311. https:\/\/doi.org\/10.1016\/j.acthis.2018.03.007.","journal-title":"Acta Histochem"},{"key":"703_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3390\/colloids2030035","volume":"2","author":"E Kaczorek","year":"2018","unstructured":"Kaczorek E, Pacholak A, Zdarta A, Smu\u0142ek W. The impact of biosurfactants on microbial cell properties leading to hydrocarbon bioavailability increase. Colloids Interfaces. 2018;2:35. https:\/\/doi.org\/10.3390\/colloids2030035.","journal-title":"Colloids Interfaces"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00703-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-025-00703-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-025-00703-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T12:59:48Z","timestamp":1742216388000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-025-00703-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["703"],"URL":"https:\/\/doi.org\/10.1007\/s43440-025-00703-y","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}